CoChat

Recent developments in the use of nanoparticles for treatment of biofilms

Open access
Han, Chendong, Romero, Nicholas, Fischer, Stephen, Dookran, Julia, Berger, Aaron, Doiron, Amber L. · 2017 · Nanotechnology Reviews

The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.

Abstract

Chronic infections have posed a tremendous burden on health care systems worldwide. Approximately 60% of chronic infections are estimated to be related to biofilms, in large part due to the extraordinary antibiotic resistance of biofilm bacteria. Nanoparticle (NP)-based therapies are viable approaches to treat biofilm-associated infections due to NPs’ unique chemical and physical properties, granted by their high surface area to volume ratio. The mechanism underlying the anti-biofilm activity of various types of NPs is actively under investigation. Simply comparing biofilm disruption or reduction rates is not adequate to describe the effectiveness of NPs; many other factors need to be taken into account, such as the NP type, bacterial strain, concentration of NPs, quantification methods, and the biofilm culture environment. This review focuses on recent research on the creation, characterization, and evaluation of NPs for the prevention or treatment of biofilm infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/ntrev-2016-0054

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 149

  1. [3] Abidi SH, Sherwani SK, Siddiqui TR, Bashir A, Kazmi SU. Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan. BMC Ophthalmol. 2013, 13, 57.10.1186/1471-2415-13-57Search in Google Scholar PubMed PubMed Central · doi:10.1186/1471-2415-13-57search
  2. [40] Subbiahdoss G, Sharifi S, Grijpma DW, Laurent S, van der Mei HC, Mahmoudi M, Busscher HJ. Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci. Acta Biomater. 2012, 8, 2047–2055.10.1016/j.actbio.2012.03.002Search in Google Scholar PubMed · doi:10.1016/j.actbio.2012.03.002search
  3. [22] Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science 1994, 263, 1600–1603.10.1126/science.8128245Search in Google Scholar PubMed · doi:10.1126/science.8128245search
  4. [84] Berney M, Hammes F, Bosshard F, Weilenmann HU, Egli T. Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight Kit in combination with flow cytometry. Appl. Environ. Microbiol. 2007, 73, 3283–3290.10.1128/AEM.02750-06Search in Google Scholar PubMed PubMed Central · doi:10.1128/aem.02750-06search
  5. [23] d’Angelo I, Casciaro B, Miro A, Quaglia F, Mangoni ML, Ungaro F. Overcoming barriers in Pseudomonas aeruginosa lung infections: engineered nanoparticles for local delivery of a cationic antimicrobial peptide. Colloids Surf. B Biointerfaces. 2015, 135, 717–725.10.1016/j.colsurfb.2015.08.027Search in Google Scholar PubMed · doi:10.1016/j.colsurfb.2015.08.027search
  6. [26] Radovic-Moreno A F, Lu TK, Puscasu VA, Yoon CJ, Langer R, Farokhzad OC. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano. 2012, 6, 4279–4287.10.1021/nn3008383Search in Google Scholar PubMed PubMed Central · doi:10.1021/nn3008383search
  7. [17] Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, Laxminarayan R. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect. Dis. 2014, 14, 742–750.10.1016/S1473-3099(14)70780-7Search in Google Scholar PubMed · doi:10.1016/s1473-3099(14)70780-7search
  8. [38] Cheow WS, Chang MW, Hadinoto K. The roles of lipid in anti-biofilm efficacy of lipid–polymer hybrid nanoparticles encapsulating antibiotics. Colloids Surf. Physicochem. Eng. Asp. 2011, 389, 158–165.10.1016/j.colsurfa.2011.08.035Search in Google Scholar · doi:10.1016/j.colsurfa.2011.08.035search
  9. [51] Chorell E, Bengtsson C, Sainte-Luce Banchelin T, Das P, Uvell H, Sinha AK, Pinkner JS, Hultgren SJ, Almqvist F. Synthesis and application of a bromomethyl substituted scaffold to be used for efficient optimization of anti-virulence activity. Eur. J. Med. Chem. 2011, 46, 1103–1116.10.1016/j.ejmech.2011.01.025Search in Google Scholar PubMed PubMed Central · doi:10.1016/j.ejmech.2011.01.025search
  10. [1] Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999, 284, 1318–1322.10.1126/science.284.5418.1318Search in Google Scholar PubMed · doi:10.1126/science.284.5418.1318search
  11. [6] Santos APA, Watanabe E, de Andrade D. Biofilm on artificial pacemaker: fiction or reality? Arq. Bras. Cardiol. 2011, 97, e113–e120.10.1590/S0066-782X2011001400018Search in Google Scholar PubMed · doi:10.1590/s0066-782x2011001400018search
  12. [21] Lacy MK, Nicolau DP, Nightingale CH, Quintiliani R. The pharmacodynamics of aminoglycosides. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 1998, 27, 23–27.10.1086/514620Search in Google Scholar PubMed · doi:10.1086/514620search
  13. [16] Ray PC, Khan SA, Singh AK, Senapati D, Fan Z. Nanomaterials for targeted detection and photothermal killing of bacteria. Chem. Soc. Rev. 2012, 41, 3193.10.1039/c2cs15340hSearch in Google Scholar PubMed · doi:10.1039/c2cs15340hsearch
  14. [15] Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 2010, 8, 260–271.10.1038/nrmicro2319Search in Google Scholar PubMed · doi:10.1038/nrmicro2319search
  15. [41] Taheri S, Baier G, Majewski P, Barton M, Förch R, Landfester K, Vasilev K. Synthesis and surface immobilization of antibacterial hybrid silver-poly(l-lactide) nanoparticles. Nanotechnology. 2014, 25, 305102.10.1088/0957-4484/25/30/305102Search in Google Scholar PubMed · doi:10.1088/0957-4484/25/30/305102search
  16. [36] Hua X, Tan S, Bandara HMHN, Fu Y, Liu S, Smyth HDC. Externally controlled triggered-release of drug from PLGA micro and nanoparticles. PLoS One 2014, 9, e114271.10.1371/journal.pone.0114271Search in Google Scholar PubMed PubMed Central · doi:10.1371/journal.pone.0114271search
  17. [44] Durmus NG, Taylor EN, Kummer KM, Webster TJ. Enhanced efficacy of superparamagnetic iron oxide nanoparticles against antibiotic-resistant biofilms in the presence of metabolites. Adv. Mater. 2013, 25, 5706–5713.10.1002/adma.201302627Search in Google Scholar PubMed · doi:10.1002/adma.201302627search
  18. [134] Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 1987, 84, 9265–9269.10.1073/pnas.84.24.9265Search in Google Scholar PubMed PubMed Central · doi:10.1073/pnas.84.24.9265search
  19. [42] Shrestha A, Hamblin MR, Kishen A. Photoactivated rose bengal functionalized chitosan nanoparticles produce antibacterial/biofilm activity and stabilize dentin-collagen. Nanomedicine Nanotechnol. Biol. Med. 2014, 10, 491–501.10.1016/j.nano.2013.10.010Search in Google Scholar PubMed PubMed Central · doi:10.1016/j.nano.2013.10.010search
  20. [93] Gogoi SK, Gopinath P, Paul A, Ramesh A, Ghosh SS, Chattopadhyay A. Green fluorescent protein-expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Langmuir 2006, 22, 9322–9328.10.1021/la060661vSearch in Google Scholar PubMed · doi:10.1021/la060661vsearch
  21. [5] Høiby N, Ciofu O, Bjarnsholt T. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol. 2010, 5, 1663–1674.10.2217/fmb.10.125Search in Google Scholar PubMed · doi:10.2217/fmb.10.125search
  22. [19] Barenholz Y. Doxil®–the first FDA-approved nano-drug: lessons learned. J. Control. Release Off. J. Control. Release Soc. 2012, 160, 117–134.10.1016/j.jconrel.2012.03.020Search in Google Scholar · doi:10.1016/j.jconrel.2012.03.020search
  23. [30] Jena P, Mohanty S, Mallick R, Jacob B, Sonawane A. Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells. Int. J. Nanomedicine 2012, 7, 1805–1818.10.2147/IJN.S28077Search in Google Scholar PubMed PubMed Central · doi:10.2147/ijn.s28077search
  24. [9] Tran PL, Lowry N, Campbell T, Reid TW, Webster DR, Tobin E, Aslani A, Mosley T, Dertien J, Colmer-Hamood JA, Hamood AN. An organoselenium compound inhibits Staphylococcus aureus biofilms on hemodialysis catheters in vivo. Antimicrob. Agents Chemother. 2012, 56, 972–978.10.1128/AAC.05680-11Search in Google Scholar PubMed PubMed Central · doi:10.1128/aac.05680-11search
  25. [71] Parsek MR, Greenberg EP. Sociomicrobiology: the connections between quorum sensing and biofilms. Trends Microbiol. 2005, 13, 27–33.10.1016/j.tim.2004.11.007Search in Google Scholar PubMed · doi:10.1016/j.tim.2004.11.007search
  26. [4] Donlan RM. Biofilms and device-associated infections. Emerg. Infect. Dis. 2001, 7, 277–281.10.3201/eid0702.010226Search in Google Scholar PubMed PubMed Central · doi:10.3201/eid0702.010226search
  27. [55] Hughes KA, Sutherland IW, Jones MV. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiol. Read. Engl. 1998, 144(Pt 11), 3039–3047.10.1099/00221287-144-11-3039Search in Google Scholar PubMed · doi:10.1099/00221287-144-11-3039search
  28. [45] Salunke GR, Ghosh S, Santosh Kumar RJ, Khade S, Vashisth P, Kale T, Chopade S, Pruthi V, Kundu G, Bellare JR, Chopade BA. Rapid efficient synthesis and characterization of silver, gold, and bimetallic nanoparticles from the medicinal plant Plumbago zeylanica and their application in biofilm control. Int. J. Nanomedicine 2014, 9, 2635–2653.10.2147/IJN.S59834Search in Google Scholar PubMed PubMed Central · doi:10.2147/ijn.s59834search
  29. [82] Sun L, Zhang C, Li P. Characterization, antibiofilm, and mechanism of action of novel PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol. J. Agric. Food Chem. 2012, 60, 6150–6156.10.1021/jf3010405Search in Google Scholar PubMed · doi:10.1021/jf3010405search
  30. [104] Masadeh MM, Karasneh GA, Al-Akhras MA, Albiss BA, Aljarah KM, Al-Azzam SI, Alzoubi KH. Cerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteria. Cytotechnology 2015, 67, 427–435.10.1007/s10616-014-9701-8Search in Google Scholar PubMed PubMed Central · doi:10.1007/s10616-014-9701-8search
  31. [143] Zhang W, Zhang YH, Ji JH, Zhao J, Yan Q, Chu PK. Antimicrobial properties of copper plasma-modified polyethylene. Polymer 2006, 47, 7441–7445.10.1016/j.polymer.2006.08.057Search in Google Scholar · doi:10.1016/j.polymer.2006.08.057search
  32. [31] Palanisamy NK, Ferina N, Amirulhusni AN, Mohd-Zain Z, Hussaini J, Ping LJ, Durairaj R. Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa. J. Nanobiotechnology 2014, 12, 2.10.1186/1477-3155-12-2Search in Google Scholar PubMed PubMed Central · doi:10.1186/1477-3155-12-2search
  33. [78] Thukkaram M, Sitaram S., Kannaiyan SK, Subbiahdoss G. Antibacterial efficacy of iron-oxide nanoparticles against biofilms on different biomaterial surfaces. Int. J. Biomater. 2014, 2014, 716080.10.1155/2014/716080Search in Google Scholar PubMed PubMed Central · doi:10.1155/2014/716080search
  34. [63] Taylor PK, Yeung ATY, Hancock REW. Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies. J. Biotechnol. 2014, 191, 121–130.10.1016/j.jbiotec.2014.09.003Search in Google Scholar PubMed · doi:10.1016/j.jbiotec.2014.09.003search
  35. [43] Taylor EN, Kummer KM, Durmus NG, Leuba K, Tarquinio KM, Webster TJ. Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms. Small 2012, 8, 3016–3027.10.1002/smll.201200575Search in Google Scholar PubMed · doi:10.1002/smll.201200575search
  36. [77] Gao L, Giglio KM, Nelson JL, Sondermann H, Travis AJ. Ferromagnetic nanoparticles with peroxidase-like activity enhance the cleavage of biological macromolecules for biofilm elimination. Nanoscale 2014, 6, 2588–2593.10.1039/C3NR05422ESearch in Google Scholar PubMed PubMed Central · doi:10.1039/c3nr05422esearch
  37. [110] Dwidjosiswojo Z, Richard J, Moritz MM, Dopp E, Flemming HC, Wingender J. Influence of copper ions on the viability and cytotoxicity of Pseudomonas aeruginosa under conditions relevant to drinking water environments. Int. J. Hyg. Environ. Health 2011, 214, 485–492.10.1016/j.ijheh.2011.06.004Search in Google Scholar PubMed · doi:10.1016/j.ijheh.2011.06.004search
  38. [59] Walsh C, and Wright G. Introduction: antibiotic resistance. Chem. Rev. 2005, 105, 391–394.10.1021/cr030100ySearch in Google Scholar PubMed · doi:10.1021/cr030100ysearch
  39. [28] Chávez de Paz LE, Resin A, Howard KA, Sutherland DS, Wejse PL. Antimicrobial effect of chitosan nanoparticles on streptococcus mutans biofilms. Appl. Environ. Microbiol. 2011, 77, 3892–3895.10.1128/AEM.02941-10Search in Google Scholar PubMed PubMed Central · doi:10.1128/aem.02941-10search
  40. [53] Qin Z, Yang L, Qu D, Molin S, Tolker-Nielsen T. Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiol. Read. Engl. 2009, 155(Pt 7), 2148–2156.10.1099/mic.0.028001-0Search in Google Scholar PubMed · doi:10.1099/mic.0.028001-0search
  41. 2016, Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa, Curr. Microbiol., 73, 747, 10.1007/s00284-016-1101-1 · DOI
  42. [80] Jaiswal S, Bhattacharya K, McHale P, Duffy B. Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity. J. Mater. Sci. Mater. Med. 2015, 26, 1–10.10.1007/s10856-014-5367-1Search in Google Scholar PubMed · doi:10.1007/s10856-014-5367-1search
  43. [14] Kim MH, Yamayoshi I, Mathew S, Lin H, Nayfach J, Simon SI. Magnetic nanoparticle targeted hyperthermia of cutaneous Staphylococcus aureus infection. Ann. Biomed. Eng. 2013, 41, 598–609.10.1007/s10439-012-0698-xSearch in Google Scholar PubMed · doi:10.1007/s10439-012-0698-xsearch
  44. [24] Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Deliv. Rev. 2013, 65, 1803–1815.10.1016/j.addr.2013.07.011Search in Google Scholar PubMed · doi:10.1016/j.addr.2013.07.011search
  45. [39] Khan S, Alam F, Azam A, Khan AU. Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm. Int. J. Nanomedicine 2012, 7, 3245–3257.10.2147/IJN.S31219Search in Google Scholar PubMed PubMed Central · doi:10.2147/ijn.s31219search
  46. [69] Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents. 2010, 35, 322–332.10.1016/j.ijantimicag.2009.12.011Search in Google Scholar PubMed · doi:10.1016/j.ijantimicag.2009.12.011search
  47. 2013, Prosthesis infections after orthopedic joint replacement: the possible role of bacterial biofilms, Orthop. Rev., 5, 65
  48. [27] Chen CP, Chen CT, Tsai T. Chitosan nanoparticles for antimicrobial photodynamic inactivation: characterization and in vitro investigation. Photochem. Photobiol. 2012, 88, 570–576.10.1111/j.1751-1097.2012.01101.xSearch in Google Scholar PubMed · doi:10.1111/j.1751-1097.2012.01101.xsearch
  49. [49] Flemming HC, Wingender J. The biofilm matrix. Nat. Rev. Microbiol. 2010, 8, 623–633.10.1038/nrmicro2415Search in Google Scholar PubMed · doi:10.1038/nrmicro2415search
  50. [35] Baelo A, Levato R, Julián E, Crespo A, Astola J, Gavaldà J, Engel E, Mateos-Timoneda MA, Torrents E. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. J. Controlled Release 2015, 209, 150–158.10.1016/j.jconrel.2015.04.028Search in Google Scholar PubMed · doi:10.1016/j.jconrel.2015.04.028search
  51. 2015, Mucosal biofilm detection in chronic otitis media: a study of middle ear biopsies from Greenlandic patients, Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. EUFOS Affil. Ger. Soc. Oto-Rhino-Laryngol. Head Neck Surg., 272, 1079
  52. [66] Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect. 2003, 5, 1213–1219.10.1016/j.micinf.2003.08.009Search in Google Scholar PubMed · doi:10.1016/j.micinf.2003.08.009search
  53. [74] Maseda H, Sawada I, Saito K, Uchiyama H, Nakae T, Nomura N. Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2004, 48, 1320–1328.10.1128/AAC.48.4.1320-1328.2004Search in Google Scholar PubMed PubMed Central · doi:10.1128/aac.48.4.1320-1328.2004search
  54. [60] Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int. J. Med. Microbiol. 2002, 292, 107–113.10.1078/1438-4221-00196Search in Google Scholar PubMed · doi:10.1078/1438-4221-00196search
  55. [50] Cegelski L, Pinkner JS, Hammer ND, Cusumano CK, Hung CS, Chorell E, Aberg V, Walker JN, Seed PC, Almqvist F, Chapman MR, Hultgren SJ. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat. Chem. Biol. 2009, 5, 913–919.10.1038/nchembio.242Search in Google Scholar PubMed PubMed Central · doi:10.1038/nchembio.242search
  56. [61] Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 2000, 44, 1818–1824.10.1128/AAC.44.7.1818-1824.2000Search in Google Scholar PubMed PubMed Central · doi:10.1128/aac.44.7.1818-1824.2000search
  57. [8] Tollefson DF, Bandyk DF, Kaebnick HW, Seabrook GR, Towne JB. Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses. Arch. Surg. Chic. Ill 1960. 1987, 122, 38–43.Search in Google Scholar
  58. [127] Song HY, Li Y. Can eradication rate of gastric Helicobacter pylori be improved by killing oral Helicobacter pylori? World J. Gastroenterol. 2013, 19, 6645–6650.10.3748/wjg.v19.i39.6645Search in Google Scholar PubMed · doi:10.3748/wjg.v19.i39.6645search
  59. [107] LewisOscar F, MubarakAli D, Nithya C, Priyanka R, Gopinath V, Alharbi NS, Thajuddin N. One pot synthesis and anti-biofilm potential of copper nanoparticles (CuNPs) against clinical strains of Pseudomonas aeruginosa. Biofouling 2015, 31, 379–391.10.1080/08927014.2015.1048686Search in Google Scholar PubMed · doi:10.1080/08927014.2015.1048686search
  60. 1987, Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses, Arch. Surg. Chic. Ill 1960., 122, 38
  61. [83] Huang YC, Li RY, Chen JY, Chen JK. Biphasic release of gentamicin from chitosan/fucoidan nanoparticles for pulmonary delivery. Carbohydr. Polym. 2016, 138, 114–122.10.1016/j.carbpol.2015.11.072Search in Google Scholar PubMed · doi:10.1016/j.carbpol.2015.11.072search
  62. [25] Maeda H. Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. Proc. Jpn. Acad. Ser. B. 2012, 88, 53–71.10.2183/pjab.88.53Search in Google Scholar PubMed PubMed Central · doi:10.2183/pjab.88.53search
  63. [67] Lewis K. Persister cells and the riddle of biofilm survival. Biochem. Biochemistry (Moscow). 2005, 70, 267–274.10.1007/s10541-005-0111-6Search in Google Scholar PubMed · doi:10.1007/s10541-005-0111-6search
  64. [72] Rasamiravaka T, El Jaziri M. Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa. Curr. Microbiol. 2016, 73, 747–753.10.1007/s00284-016-1101-1Search in Google Scholar PubMed · doi:10.1007/s00284-016-1101-1search
  65. 2012, Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection, Int. J. Nanomedicine, 7, 4053
  66. [58] Brooks BD, Brooks AE. Therapeutic strategies to combat antibiotic resistance. Adv. Drug Deliv. Rev. 2014, 78, 14–27.10.1016/j.addr.2014.10.027Search in Google Scholar PubMed · doi:10.1016/j.addr.2014.10.027search
  67. [57] Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature. 2000, 406, 775–781.10.1038/35021219Search in Google Scholar PubMed · doi:10.1038/35021219search
  68. [12] Hajipour MJ, Fromm KM, Ashkarran AA, Jimenez de Aberasturi D, de Larramendi IR, Rojo T, Serpooshan V, Parak WJ, Mahmoudi M. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012, 30, 499–511.10.1016/j.tibtech.2012.06.004Search in Google Scholar PubMed · doi:10.1016/j.tibtech.2012.06.004search
  69. [34] Dong D, Thomas N, Thierry B, Vreugde S, Prestidge CA, Wormald PJ. Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm. PLoS One 2015, 10, e0131806.10.1371/journal.pone.0131806Search in Google Scholar PubMed PubMed Central · doi:10.1371/journal.pone.0131806search
  70. [86] Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J. Microbiol. Methods 2008, 72, 157–165.10.1016/j.mimet.2007.11.010Search in Google Scholar PubMed · doi:10.1016/j.mimet.2007.11.010search
  71. [95] Wilson M, Dobson J, Harvey W. Sensitization of oral bacteria to killing by low-power laser radiation. Curr. Microbiol. 1992, 25, 77–81.10.1007/BF01570963Search in Google Scholar PubMed · doi:10.1007/bf01570963search
  72. [79] Mohanty S, Mishra S, Jena P, Jacob B, Sarkar B, Sonawane A. An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2012, 8, 916–924.10.1016/j.nano.2011.11.007Search in Google Scholar PubMed · doi:10.1016/j.nano.2011.11.007search
  73. [46] Ramasamy M, Lee JH, Lee J. Potent antimicrobial and antibiofilm activities of bacteriogenically synthesized gold-silver nanoparticles against pathogenic bacteria and their physiochemical characterizations. J. Biomater. Appl. 2016, 31, 366–378.10.1177/0885328216646910Search in Google Scholar PubMed · doi:10.1177/0885328216646910search
  74. [64] Singh R, Paul D, Jain RK. Biofilms: implications in bioremediation. Trends Microbiol. 2006, 14, 389–397.10.1016/j.tim.2006.07.001Search in Google Scholar PubMed · doi:10.1016/j.tim.2006.07.001search
  75. [65] Umadevi S, Joseph NM, Kumari K, Easow JM, Kumar S, Stephen S, Srirangaraj S, Raj S. Detection of extended spectrum beta lactamases, ampc beta lactamases and metallobetalactamases in clinical isolates of ceftazidime resistant Pseudomonas Aeruginosa. Braz. J. Microbiol. 2011, 42, 1284–1288.10.1590/S1517-83822011000400006Search in Google Scholar PubMed PubMed Central · doi:10.1590/s1517-83822011000400006search
  76. [75] Rasamiravaka T, Jaziri ME. Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa. Curr. Microbiol. 2016, 73, 747–753.10.1007/s00284-016-1101-1Search in Google Scholar · doi:10.1007/s00284-016-1101-1search
  77. [47] Cai J, Huang H, Song W, Hu H, Chen J, Zhang L, Li P, Wu R, Wu C. Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro. Int. J. Pharm. 2015, 495, 728–737.10.1016/j.ijpharm.2015.09.055Search in Google Scholar PubMed · doi:10.1016/j.ijpharm.2015.09.055search
  78. [87] Radzig MA, Nadtochenko VA, Koksharova OA, Kiwi J, Lipasova VA, Khmel IA. Antibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action. Colloids Surf. B Biointerfaces 2013, 102, 300–306.10.1016/j.colsurfb.2012.07.039Search in Google Scholar PubMed · doi:10.1016/j.colsurfb.2012.07.039search
  79. [96] Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26, 3995–4021.10.1016/j.biomaterials.2004.10.012Search in Google Scholar PubMed · doi:10.1016/j.biomaterials.2004.10.012search
  80. [109] Kruk T, Szczepanowicz K, Stefańska J, Socha RP, Warszyński P. Synthesis and antimicrobial activity of monodisperse copper nanoparticles. Colloids Surf. B Biointerfaces 2015, 128, 17–22.10.1016/j.colsurfb.2015.02.009Search in Google Scholar PubMed · doi:10.1016/j.colsurfb.2015.02.009search
  81. [33] Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 2009, 30, 2782–2789.10.1016/j.biomaterials.2009.01.052Search in Google Scholar PubMed PubMed Central · doi:10.1016/j.biomaterials.2009.01.052search
  82. [48] Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 2002, 56, 187–209.10.1146/annurev.micro.56.012302.160705Search in Google Scholar PubMed · doi:10.1146/annurev.micro.56.012302.160705search
  83. [92] Su HL, Chou CC, Hung DJ, Lin SH, Pao IC, Lin JH, Huang FL, Dong RX, Lin JJ. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials 2009, 30, 5979–5987.10.1016/j.biomaterials.2009.07.030Search in Google Scholar PubMed · doi:10.1016/j.biomaterials.2009.07.030search
  84. [18] Habash MB, Park AJ, Vis EC, Harris RJ, Khursigara CM. Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms. Antimicrob. Agents Chemother. 2014, 58, 5818–5830.10.1128/AAC.03170-14Search in Google Scholar PubMed · doi:10.1128/aac.03170-14search
  85. [32] Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf. B Biointerfaces 2010, 79, 340–344.10.1016/j.colsurfb.2010.04.014Search in Google Scholar PubMed · doi:10.1016/j.colsurfb.2010.04.014search
  86. [123] Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J. Controlled Release 2008, 125, 193–209.10.1016/j.jconrel.2007.09.013Search in Google Scholar PubMed · doi:10.1016/j.jconrel.2007.09.013search
  87. [89] Williams DF. On the mechanisms of biocompatibility. Biomaterials 2008, 29, 2941–2953.10.1016/j.biomaterials.2008.04.023Search in Google Scholar PubMed · doi:10.1016/j.biomaterials.2008.04.023search
  88. [133] Zelver N, Hamilton M, Pitts B, Goeres D, Walker D, Sturman P, Heersink J. Measuring antimicrobial effects on biofilm bacteria: from laboratory to field. Methods Enzymol. 1999, 310, 608–628.10.1016/S0076-6879(99)10047-8Search in Google Scholar PubMed · doi:10.1016/s0076-6879(99)10047-8search
  89. [52] Han Z, Pinkner JS, Ford B, Obermann R, Nolan W, Wildman SA, Hobbs D, Ellenberger T, Cusumano CK, Hultgren SJ, Janetka JW. Structure-based drug design and optimization of mannoside bacterial FimH antagonists. J. Med. Chem. 2010, 53, 4779–4792.10.1021/jm100438sSearch in Google Scholar PubMed PubMed Central · doi:10.1021/jm100438ssearch
  90. 2012, Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm, Int. J. Nanomedicine, 7, 3245
  91. [90] Gurunathan S, Han JW, Kwon DN, Kim JH. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res. Lett. 2014, 9, 373.10.1186/1556-276X-9-373Search in Google Scholar PubMed PubMed Central · doi:10.1186/1556-276x-9-373search
  92. [94] Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as amodel for Gram-negative bacteria. J. Colloid Interface Sci. 2004, 275, 177–182.10.1016/j.jcis.2004.02.012Search in Google Scholar PubMed · doi:10.1016/j.jcis.2004.02.012search
  93. [124] Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000, 21, 2475–2490.10.1016/S0142-9612(00)00115-0Search in Google Scholar PubMed · doi:10.1016/s0142-9612(00)00115-0search
  94. [73] Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407, 762–764.10.1038/35037627Search in Google Scholar PubMed · doi:10.1038/35037627search
  95. [76] De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 2008, 3, 133–149.10.2147/IJN.S596Search in Google Scholar · doi:10.2147/ijn.s596search
  96. [120] Del Carpio-Perochena A, Bramante CM, Duarte MAH, de Moura MR, Aouada FA, Kishen A. Chelating and antibacterial properties of chitosan nanoparticles on dentin. Restor. Dent. Endod. 2015, 40, 195–201.10.5395/rde.2015.40.3.195Search in Google Scholar PubMed PubMed Central · doi:10.5395/rde.2015.40.3.195search
  97. [54] Boyd A, Chakrabarty AM. Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl. Environ. Microbiol. 1994, 60, 2355–2359.10.1128/aem.60.7.2355-2359.1994Search in Google Scholar PubMed PubMed Central · doi:10.1128/aem.60.7.2355-2359.1994search
  98. [20] Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. Sci. 2002, 6, 319–327.10.1016/S1359-0286(02)00117-1Search in Google Scholar · doi:10.1016/s1359-0286(02)00117-1search
  99. [85] Welch K, Cai Y, Strømme M. A method for quantitative determination of biofilm viability. J. Funct. Biomater. 2012, 3, 418–431.10.3390/jfb3020418Search in Google Scholar PubMed PubMed Central · doi:10.3390/jfb3020418search
  100. [131] Herigstad B, Hamilton M, Heersink J. How to optimize the drop plate method for enumerating bacteria. J. Microbiol. Methods 2001, 44, 121–129.10.1016/S0167-7012(00)00241-4Search in Google Scholar PubMed · doi:10.1016/s0167-7012(00)00241-4search
  101. [129] Kho K, Cheow WS, Lie RH, Hadinoto K. Aqueous re-dispersibility of spray-dried antibiotic-loaded polycaprolactone nanoparticle aggregates for inhaled anti-biofilm therapy. Powder Technol. 2010, 203, 432–439.10.1016/j.powtec.2010.06.003Search in Google Scholar · doi:10.1016/j.powtec.2010.06.003search
  102. [141] Jones DS, Djokic J, Gorman SP. The resistance of polyvinylpyrrolidone-iodine-poly(-caprolactone) blends to adherence of Escherichia coli. Biomaterials 2005, 26, 2013–2020.10.1016/j.biomaterials.2004.06.001Search in Google Scholar PubMed · doi:10.1016/j.biomaterials.2004.06.001search
  103. [70] Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998, 280, 295–298.10.1126/science.280.5361.295Search in Google Scholar PubMed · doi:10.1126/science.280.5361.295search
  104. [116] Messiaen AS, Forier K, Nelis H, Braeckmans K, Coenye T. Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms. PLoS One 2013, 8, e79220.10.1371/journal.pone.0079220Search in Google Scholar PubMed PubMed Central · doi:10.1371/journal.pone.0079220search
  105. [111] Tabrez S, Khan, Ahamed M, Al-Khedhairy A, Musarrat J. Biocidal effect of copper and zinc oxide nanoparticles on human oral microbiome and biofilm formation. Mater. Lett. 2013, 97, 67–70.10.1016/j.matlet.2013.01.085Search in Google Scholar · doi:10.1016/j.matlet.2013.01.085search
  106. [139] Forier K, Messiaen AS, Raemdonck K, Nelis H, De Smedt S, Demeester J, Coenye T, Braeckmans K. Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilms. J. Controlled Release 2014, 195, 21–28.10.1016/j.jconrel.2014.07.061Search in Google Scholar PubMed · doi:10.1016/j.jconrel.2014.07.061search
  107. [68] Dawson CC, Intapa C, Jabra-Rizk MA. ‘Persisters’: survival at the cellular level. PLoS Pathog. 2011, 7, e1002121.10.1371/journal.ppat.1002121Search in Google Scholar PubMed PubMed Central · doi:10.1371/journal.ppat.1002121search
  108. [142] Yuan Y, Ai F, Zang X, Zhuang W, Shen J, Lin S. Polyurethane vascular catheter surface grafted with zwitterionic sulfobetaine monomer activated by ozone. Colloids Surf. B Biointerfaces 2004, 35, 1–5.10.1016/j.colsurfb.2004.01.005Search in Google Scholar PubMed · doi:10.1016/j.colsurfb.2004.01.005search
  109. [114] Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int. J. Nanomedicine 2012, 7, 49–60.10.2147/IJN.S26766Search in Google Scholar PubMed PubMed Central · doi:10.2147/ijn.s26766search
  110. [99] Lu AH, Salabas EL, Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 2007, 46, 1222–1244.10.1002/anie.200602866Search in Google Scholar PubMed · doi:10.1002/anie.200602866search
  111. [29] Tan Y, Ma S, Liu C, Yu W, Han F. Enhancing the stability and antibiofilm activity of DspB by immobilization on carboxymethyl chitosan nanoparticles. Microbiol. Res. 2015, 178, 35–41.10.1016/j.micres.2015.06.001Search in Google Scholar PubMed · doi:10.1016/j.micres.2015.06.001search
  112. [137] Slomberg DL, Lu Y, Broadnax AD, Hunter RA, Carpenter AW, Schoenfisch MH. Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles. ACS Appl. Mater. Interfaces 2013, 5, 9322–9329.10.1021/am402618wSearch in Google Scholar PubMed · doi:10.1021/am402618wsearch
  113. [81] Cheow WS, Hadinoto K. Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles. Particuology, 2012, 10, 327–333.10.1016/j.partic.2011.08.007Search in Google Scholar · doi:10.1016/j.partic.2011.08.007search
  114. [122] Hassani Najafabadi A, Abdouss M, Faghihi S. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen. Mater. Sci. Eng. C 2014, 41, 91–99.10.1016/j.msec.2014.04.035Search in Google Scholar PubMed · doi:10.1016/j.msec.2014.04.035search
  115. [11] Wu H, Moser C, Wang HZ, Høiby N, Song ZJ. Strategies for combating bacterial biofilm infections. Int. J. Oral Sci. 2015, 7, 1–7.10.1038/ijos.2014.65Search in Google Scholar PubMed PubMed Central · doi:10.1038/ijos.2014.65search
  116. [108] Ren G, Hu D, Cheng EWC, Vargas-Reus MA, Reip P, Allaker RP. Characterisation of copper oxide nanoparticles for antimicrobial applications. Int. J. Antimicrob. Agents 2009, 33, 587–590.10.1016/j.ijantimicag.2008.12.004Search in Google Scholar PubMed · doi:10.1016/j.ijantimicag.2008.12.004search
  117. [101] Kennedy J, Blair IS, McDowell DA, Bolton DJ. An investigation of the thermal inactivation of Staphylococcus aureus and the potential for increased thermotolerance as a result of chilled storage. J. Appl. Microbiol. 2005, 99, 1229–1235.10.1111/j.1365-2672.2005.02697.xSearch in Google Scholar PubMed · doi:10.1111/j.1365-2672.2005.02697.xsearch
  118. [145] Curtis LT. Prevention of hospital-acquired infections: review of non-pharmacological interventions. J. Hosp. Infect. 2008, 69, 204–219.10.1016/j.jhin.2008.03.018Search in Google Scholar PubMed PubMed Central Received: 2016-7-1 Accepted: 2016-10-18 Published Online: 2017-1-13 Published in Print: 2017-10-26 ©2017 Walter de Gruyter GmbH, Berlin/Boston This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Skip Articles in the same Issue Articles in the same Issue Frontmatter In this issue Reviews Recent developments in the use of nanoparticles for treatment of biofilms Biomaterial-based nanoreactors, an alternative for enzyme delivery The role of defects and dimensionality in influencing the charge, capacitance, and energy storage of graphene and 2D materials Hydrogel based 3D carriers in the application of stem cell therapy by direct injection Magnetic targeting with superparamagnetic iron oxide nanoparticles for in vivo glioma Nanomaterials for cancer therapies Readers are also interested in: article: Mechanical and thermal characterization of Kevlar–Basalt hybrid composites reinforced with Al2O3 nanoparticles Mechanical and thermal characterization of Kevlar–Basalt hybrid composites reinforced with Al2O3 nanoparticles article: A bibliometric and visual analysis of the current status and future prospects of nanotechnology in fracture healing research(1995–2025) A bibliometric and visual analysis of the current status and future prospects of nanotechnology in fracture healing research(1995–2025) article: Improving bending fatigue lifetime and interfacial adhesion of Cu–Mn flexible interconnects using self-forming nanolayer Improving bending fatigue lifetime and interfacial adhesion of Cu–Mn flexible interconnects using self-forming nanolayer https://doi.org/10.1515/ntrev-2016-0054 Keywords for this article antibiotic resistance; bacterial infection; biofilm; drug delivery; nanoparticles Creative Commons BY-NC-ND 3.0 Skip Articles in the same Issue Articles in the same Issue Frontmatter In this issue Reviews Recent developments in the use of nanoparticles for treatment of biofilms Biomaterial-based nanoreactors, an alternative for enzyme delivery The role of defects and dimensionality in influencing the charge, capacitance, and energy storage of graphene and 2D materials Hydrogel based 3D carriers in the application of stem cell therapy by direct injection Magnetic targeting with superparamagnetic iron oxide nanoparticles for in vivo glioma Nanomaterials for cancer therapies · doi:10.1016/j.jhin.2008.03.018search
  119. [13] Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 2001, 183, 6746–6751.10.1128/JB.183.23.6746-6751.2001Search in Google Scholar PubMed · doi:10.1128/jb.183.23.6746-6751.2001search
  120. [126] Iannitelli A, Grande R, Di Stefano A, Di Giulio M, Sozio P, Bessa LJ, Laserra S, Paolini C, Protasi F, Cellini L. Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm. Int. J. Mol. Sci. 2011, 12, 5039–5051.10.3390/ijms12085039Search in Google Scholar PubMed · doi:10.3390/ijms12085039search
  121. [105] Ramyadevi J, Jeyasubramanian K, Marikani A, Rajakumar G, Rahuman AA. Synthesis and antimicrobial activity of copper nanoparticles. Mater. Lett. 2012, 71, 114–116.10.1016/j.matlet.2011.12.055Search in Google Scholar · doi:10.1016/j.matlet.2011.12.055search
  122. [138] Seneviratne CJ, Leung KC, Wong CH, Lee SF, Li X, Leung PC, Lau CB, Wat E, Jin L. Nanoparticle-encapsulated chlorhexidine against oral bacterial biofilms. PLoS One 2014, 9, e103234.10.1371/journal.pone.0103234Search in Google Scholar PubMed PubMed Central · doi:10.1371/journal.pone.0103234search
  123. [121] de Salamanca AE, Diebold Y, Calonge M, García-Vazquez C, Callejo S, Vila A, Alonso MJ. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Investig. Opthalmology Vis. Sci. 2006, 47, 1416.10.1167/iovs.05-0495Search in Google Scholar PubMed · doi:10.1167/iovs.05-0495search
  124. [100] Yantasee W, Warner CL, Sangvanich T, Addleman RS, Carter TG, Wiacek RJ, Fryxell GE, Timchalk C, Warner MG. Removal of heavy metals from aqueous systems with thiol functionalized superparamagnetic nanoparticles. Environ. Sci. Technol. 2007, 41, 5114–5119.10.1021/es0705238Search in Google Scholar PubMed · doi:10.1021/es0705238search
  125. [98] Salunkhe AB, Khot VM, Pawar SH. Magnetic hyperthermia with magnetic nanoparticles: a status review. Curr. Top. Med. Chem. 2014, 14, 572–594.10.2174/1568026614666140118203550Search in Google Scholar PubMed · doi:10.2174/1568026614666140118203550search
  126. [135] Carpenter AW, Slomberg DL, Rao KS, Schoenfisch MH. Influence of scaffold size on bactericidal activity of nitric oxide releasing silica nanoparticles. ACS Nano 2011, 5, 7235–7244.10.1021/nn202054fSearch in Google Scholar PubMed PubMed Central · doi:10.1021/nn202054fsearch
  127. [112] Shankar S, Rhim JW. Effect of copper salts and reducing agents on characteristics and antimicrobial activity of copper nanoparticles. Mater. Lett. 2014, 132, 307–311.10.1016/j.matlet.2014.06.014Search in Google Scholar · doi:10.1016/j.matlet.2014.06.014search
  128. [132] Naghili H, Tajik H, Mardani K, Razavi Rouhani SM, Ehsani A, Zare P. Validation of drop plate technique for bacterial enumeration by parametric and nonparametric tests. Vet. Res. Forum 2013, 4, 179–183.Search in Google Scholar PubMed
  129. [140] Paladini F, Pollini M, Sannino A, Ambrosio L. Metal-based antibacterial substrates for biomedical applications. Biomacromolecules 2015, 16, 1873–1885.10.1021/acs.biomac.5b00773Search in Google Scholar PubMed · doi:10.1021/acs.biomac.5b00773search
  130. 2013, Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era, Cold Spring Harb. Perspect. Med., 3, a010306
  131. [97] Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans. Magn. 1981, 17, 1247–1248.10.1109/TMAG.1981.1061188Search in Google Scholar · doi:10.1109/tmag.1981.1061188search
  132. [118] Machul A, Mikołajczyk D, Regiel-Futyra A, Heczko PB, Strus M, Arruebo M, Stochel G, Kyzioł A. Study on inhibitory activity of chitosan-based materials against biofilm producing Pseudomonas aeruginosa strains. J. Biomater. Appl. 2015, 30, 269–278.10.1177/0885328215578781Search in Google Scholar PubMed · doi:10.1177/0885328215578781search
  133. [130] Chen CY, Nace GW, Irwin PL. A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. J. Microbiol. Methods 2003, 55, 475–479.10.1016/S0167-7012(03)00194-5Search in Google Scholar PubMed · doi:10.1016/s0167-7012(03)00194-5search
  134. 2015, Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity, J. Mater. Sci. Mater. Med., 26, 1
  135. 2015, Current development of silver nanoparticle preparation, investigation, and application in the field of medicine, current development of silver nanoparticle preparation, investigation, and application in the field of medicine, J. Nanomater. J. Nanomater., 2015, e696918, 10.1155/2015/696918 · DOI · Paper page
  136. [115] Meers P, Neville M, Malinin V, Scotto AW, Sardaryan G, Kurumunda R, Mackinson C, James G, Fisher S, Perkins WR. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J. Antimicrob. Chemother. 2008, 61, 859–868.10.1093/jac/dkn059Search in Google Scholar PubMed · doi:10.1093/jac/dkn059search
  137. [103] Borcherding J, Baltrusaitis J, Chen H, Stebounova L, Wu CM, Rubasinghege G, Mudunkotuwa IA, Caraballo JC, Zabner J, Grassian VH, Comellas AP. Iron oxide nanoparticles induce Pseudomonas aeruginosa growth, induce biofilm formation, and inhibit antimicrobial peptide function. Environ. Sci. Nano 2014, 1, 123–132.10.1039/c3en00029jSearch in Google Scholar PubMed PubMed Central · doi:10.1039/c3en00029jsearch
  138. [128] Beyth N, Yudovin-Farber I, Perez-Davidi M, Domb AJ, Weiss EI. Polyethyleneimine nanoparticles incorporated into resin composite cause cell death and trigger biofilm stress in vivo. Proc. Natl. Acad. Sci. USA. 2010, 107, 22038–22043.10.1073/pnas.1010341107Search in Google Scholar · doi:10.1073/pnas.1010341107search
  139. [102] Nguyen TK, Duong HTT, Selvanayagam R, Boyer C, Barraud N. Iron oxide nanoparticle-mediated hyperthermia stimulates dispersal in bacterial biofilms and enhances antibiotic efficacy. Sci. Rep. 2015, 5, 18385.10.1038/srep18385Search in Google Scholar PubMed PubMed Central · doi:10.1038/srep18385search
  140. 2011, Biofilm on artificial pacemaker: fiction or reality?, Arq. Bras. Cardiol., 97, e113
  141. [2] Lewis K. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 2001, 45, 999–1007.10.1128/AAC.45.4.999-1007.2001Search in Google Scholar PubMed PubMed Central · doi:10.1128/aac.45.4.999-1007.2001search
  142. [62] Walters MC, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 2003, 47, 317–323.10.1128/AAC.47.1.317-323.2003Search in Google Scholar PubMed PubMed Central · doi:10.1128/aac.47.1.317-323.2003search
  143. [117] Rabea EI, Badawy MET, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003, 4, 1457–1465.10.1021/bm034130mSearch in Google Scholar PubMed · doi:10.1021/bm034130msearch
  144. [136] Shin JH, Metzger SK, Schoenfisch MH. Synthesis of nitric oxide-releasing silica nanoparticles. J. Am. Chem. Soc. 2007, 129, 4612–4619.10.1021/ja0674338Search in Google Scholar PubMed · doi:10.1021/ja0674338search
  145. [119] Ali SW, Rajendran S, Joshi M. Synthesis and characterization of chitosan and silver loaded chitosan nanoparticles for bioactive polyester. Carbohydr. Polym. 2011, 83, 438–446.10.1016/j.carbpol.2010.08.004Search in Google Scholar · doi:10.1016/j.carbpol.2010.08.004search
  146. [113] Shek PN, Yung BY, Stanacev NZ. Comparison between multilamellar and unilamellar liposomes in enhancing antibody formation. Immunology 1983, 49, 37–44.Search in Google Scholar PubMed
  147. [125] Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int. J. Nanomedicine 2011, 6, 877–895.10.2147/IJN.S18905Search in Google Scholar PubMed · doi:10.2147/ijn.s18905search
  148. [91] Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, Kim YK, Lee YS, Jeong DH, Cho MH. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007, 3, 95–101.10.1016/j.nano.2006.12.001Search in Google Scholar PubMed · doi:10.1016/j.nano.2006.12.001search
  149. [144] Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int. J. Antimicrob. Agents 2009, 34, 103–110.10.1016/j.ijantimicag.2009.01.017Search in Google Scholar PubMed · doi:10.1016/j.ijantimicag.2009.01.017search

Cited by

See all 114

Metadata

Authors
Han, C., Romero, N., Fischer, S., Dookran, J., Berger, A., & Doiron, A. L.
Affiliations
Binghamton University (US)
Corresponding author
Doiron, Amber L.
Venue
Nanotechnology Reviews
Published
2017-10-26
Volume
6
Issue
5
Pages
383-404
ISSN
  • 2191-9089 (ISSN-L)
  • 2191-9097
OpenAlex
W2557184343
Cited by
114
References
141
Citations by year
2026: 8 · 2025: 20 · 2024: 14 · 2023: 15 · 2022: 14 · 2021: 21 · 2020: 12 · 2019: 6 · 2018: 4
FWCI
1.73
Type
journal article
Language
en
Open access
Locations
  • Nanotechnology Reviews (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
nanoparticles, biofilm, biofilm-associated infections, chronic infection, antibiotic resistance, antibiofilm activity, biofilm eradication, nanoparticle characterization, nanotherapeutics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.